The results demonstrated that the mRNA levels of RUNX2 were significantly higher in recurrent tumors and metastatic sites than those of non-recurrent ones (Fig. 8a), and the mRNA levels were closely associated with CRC TMN stages and liver/lung metastasis (Table 1). The gene discussed is RUNX2; the disease is colorectal carcinoma.